PACS Group

PACS

Market cap $5.66B

SHEL, XYZ, UAA, PACS and LAUR have been added to the Zacks Rank #1 (Strong Buy) List on April 14, 2026.

The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in PACS Group, Inc. (PACS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?

Investors with an interest in Medical Services stocks have likely encountered both PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced today that it will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Tuesday, March 17, 2026. Jason Murray, Chief Executive Officer and Chairman of the Board, and Mark Hancock, Interim Chief Financial Officer and Executive Vice Chairman of the Board.

BTSG, INNV and PACS could benefit as the medical services industry embraces digital health and analytics, though workforce shortages still pressure providers.

Three of the portfolio's 10 equity sectors made positive contributions to calendar-year period performance: Health Care and Financials led by wide margins, followed by Information Technology. PACS Group reported stronger-than-expected fiscal 2024 and year-to-date fiscal 2025 results in November of 2025, signaling that its acquisition and operating models remained on track. FTAI shares significantly outperformed in 2025 due to robust demand for passenger flights and from strengthening its moat by acquiring a new repair facility in Rome.

PACS Group, Inc. (PACS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?

The consensus price target hints at a 25.5% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.